Cleared Special

K232162 - Autotome Pro RX 39 Sphincterotome (FDA 510(k) Clearance)

Also includes:
Autotome Pro RX 44 Sphincterotome Jagtome Pro RX 44 Sphincterotome Jagtome Pro RX 39 Sphincterotome Dreamtome Pro RX 44 Sphincterotome Hydratome Pro RX 44 Sphincterotome Jagtome Revolution Pro RX 39 Sphincterotome
Aug 2023
Decision
24d
Days
Class 2
Risk

K232162 is an FDA 510(k) clearance for the Autotome Pro RX 39 Sphincterotome. This device is classified as a Unit, Electrosurgical, Endoscopic (with Or Without Accessories) (Class II - Special Controls, product code KNS).

Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on August 14, 2023, 24 days after receiving the submission on July 21, 2023.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.4300.

Submission Details

510(k) Number K232162 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 21, 2023
Decision Date August 14, 2023
Days to Decision 24 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code KNS — Unit, Electrosurgical, Endoscopic (with Or Without Accessories)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.4300

Similar Devices — KNS Unit, Electrosurgical, Endoscopic (with Or Without Accessories)

All 9
Single Use 3-Lumen Needle Knife V (KD-V441M, KD-V451M)
K252889 · Olympus Medical Systems Corporation · Nov 2025
Single Use Preloaded Sphincterotome V (Distal Wire Guided) (KD-VC600 Series)
K250945 · Olympus Medical Systems Corp. · Oct 2025
Single Use Electrosurgical Knife (KD-612L, KD-612U)
K250351 · Olympus Medical Systems Corporation · Oct 2025
Rezum System
K250584 · Boston Scientific Corporation · Jun 2025
Teslatome Bipolar Sphincterotome
K243568 · Wilson-Cook Medical, Inc. · Jan 2025
Gold Probe Bipolar Electrohemostasis Catheter
K232633 · Boston Scientific · Nov 2023